Potential for Kidney Protection Diabetes is the number one cause of chronic kidney disease
Pendulum continues to disrupt the health and wellness space by focusing on innovative ingredients, science, and effective solutions for everyone
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (surmount-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
FDA approval of tirzepatide for obstructive sleep apnea in adults with obesity
Additionally, managing stress and ensuring adequate sleep are crucial components of a healthy lifestyle that can influence fat loss
We always take our time with the consultation, whether its in the office or through telehealth